Carlito, Ephraim D.

HRN: 16-82-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
01/04/2023
01/11/2023
ORAL
3ml
Q12h
Urti
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: